Indivior Announces Q1 2023 Financial Results
Get Alerts INDV Hot Sheet
Join SI Premium – FREE
- The earnings release can be found at www.indivior.com/en/media/press-releases
- The investor presentation can be found at www.indivior.com/investors
There will be a live webcast presentation at
Webcast link: https://edge.media-server.com/mmc/p/qjdd6559
Participants may access the presentation telephonically by registering with the following link: https://register.vevent.com/register/BIa24873f5a1524c73b34c473b7761725f
(Please note this is a change from prior calls - registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid use disorder treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and cooccurring disorders of SUD. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-announces-q1-2023-financial-results-301808955.html
SOURCE Indivior PLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- DREAMO and DREAMOSIS Bring the Collectible Character Into a New Physical-Digital World
- TTW Announces the Top 50 Travel Solution Cards in the World for 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share